Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for SIGA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 165.29M
March 31, 2026 151.62M
December 31, 2025 198.82M
September 30, 2025 203.48M
June 30, 2025 209.31M
March 31, 2025 216.13M
December 31, 2024 215.80M
September 30, 2024 169.44M
June 30, 2024 167.56M
March 31, 2024 164.99M
December 31, 2023 196.86M
September 30, 2023 124.14M
June 30, 2023 124.07M
March 31, 2023 162.09M
December 31, 2022 170.16M
September 30, 2022 173.14M
June 30, 2022 139.77M
March 31, 2022 167.74M
December 31, 2021 174.31M
September 30, 2021 106.56M
June 30, 2021 116.72M
March 31, 2021 122.68M
December 31, 2020 129.79M
September 30, 2020 112.96M
June 30, 2020 94.13M
Date Value
March 31, 2020 88.14M
December 31, 2019 97.78M
September 30, 2019 102.87M
June 30, 2019 103.45M
March 31, 2019 106.07M
December 31, 2018 102.91M
September 30, 2018 52.47M
June 30, 2018 -341.32M
March 31, 2018 -334.62M
December 31, 2017 -323.14M
September 30, 2017 -312.83M
June 30, 2017 -303.41M
March 31, 2017 -296.14M
December 31, 2016 -287.42M
September 30, 2016 -313.16M
June 30, 2016 -304.07M
March 31, 2016 -294.68M
December 31, 2015 -284.43M
September 30, 2015 -264.67M
June 30, 2015 -259.39M
March 31, 2015 -253.20M
December 31, 2014 -246.50M
September 30, 2014 -227.98M
June 30, 2014 11.57M
March 31, 2014 13.94M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 597.21M
Corcept Therapeutics, Inc. 705.78M
Veru, Inc. 28.38M
Johnson & Johnson 84.97B
Eli Lilly & Co. 33.88B

Shareholders Equity (Quarterly) Related Metrics